Convenient procedures for synthesis of ciproxifan, a histamine H3-receptor antagonist

被引：0
|
作者：
Stark, H [1 ]
机构：
[1] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
来源：
ARCHIV DER PHARMAZIE | 2000年 / 333卷 / 09期
关键词：
cyclopropanes; etherifications; Mitsunobu reactions; histamine H-3 receptors; antagonists;
D O I：
10.1002/1521-4184(20009)333:9<315::AID-ARDP315>3.0.CO;2-M
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclopropyl 9-(3-(1H-imidazol-4-yl)propyloxy)phenyl methanone (ciproxifan) is a novel reference antagonist for the histamine H-3 receptor. Despite the former Mitsunobu reaction the actual key reaction for preparation based on SNAr for acylated fluoroaromatics with an additional cyclization in a one-pot procedure needs no chromatographic purification steps and results in good yields.
引用
收藏
页码：315 / 316
页数：2
相关论文
共 50 条
  • [41] SYNTHESIS AND BINDING ASSAYS OF H3-RECEPTOR LIGANDS
    BORDI, F
    MOR, M
    PLAZZI, PV
    SILVA, C
    MORINI, G
    CARETTA, A
    BAROCELLI, E
    IMPICCIATORE, M
    [J]. FARMACO, 1992, 47 (11): : 1343 - 1365
  • [42] Novel histamine H3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds
    Stark, H
    Sadek, B
    Krause, M
    Hüls, A
    Ligneau, X
    Ganellin, CR
    Arrang, JM
    Schwartz, JC
    Schunack, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) : 3987 - 3994
  • [43] NOVEL PYRROLIDINE ANALOGS OF HISTAMINE AS POTENT, HIGHLY SELECTIVE HISTAMINE H3-RECEPTOR AGONISTS
    SHIH, NY
    ASLANIAN, R
    LUPO, AT
    DUGUMA, L
    ORLANDO, S
    PIWINSKI, JJ
    GREEN, MJ
    GANGULY, AK
    CLARK, M
    TOZZI, S
    KREUTNER, W
    HEY, JA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 156 - MEDI
  • [44] Histamine H3-receptor ligands:: Effects of inverse agonists and protean ligands
    Arrang, JM
    Morisset, S
    Rouleau, A
    Gbahou, F
    Ligneau, X
    Tardivel-Lacombe, J
    Stark, H
    Schunack, W
    Ganellin, CR
    Schwartz, JC
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S141 - S141
  • [45] General construction pattern of histamine H3-receptor antagonists:: Change of a paradigm
    Stark, H
    Ligneau, X
    Arrang, JM
    Schwartz, JC
    Schunack, W
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (15) : 2011 - 2016
  • [46] Thioperamide, a histamine H3-receptor blocker, facilitates vasopressor response to footshocks
    Acuña, Y
    Mathison, Y
    Campos, HA
    Israel, A
    [J]. INFLAMMATION RESEARCH, 1998, 47 (03) : 109 - 114
  • [47] The discovery of potent non-imidazole H3-receptor histamine antagonists
    Ganellin, CR
    Leurquin, F
    Piripitsi, A
    Arrang, JM
    Garbarg, M
    Ligneau, X
    Stark, H
    Schunack, W
    Schwartz, JC
    [J]. HISTAMINE RESEARCH IN THE NEW MILLENNIUM, 2001, 1224 : 25 - 31
  • [48] Gastroprotective activity of the novel histamine H3-receptor agonist FUB 407
    G. Morini
    D. Grandi
    A. Sasse
    H. Stark
    W. Schunack
    [J]. Inflammation Research, 2001, 50 (Suppl 2) : 116 - 117
  • [49] DESIGN OF NON-THIOUREA H3-RECEPTOR HISTAMINE-ANTAGONISTS
    GANELLIN, CR
    FKYERAT, A
    HOSSEINI, SK
    TERTIUK, W
    GARBARG, M
    LIGNEAU, X
    SCHWARTZ, JC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 15 - MEDI
  • [50] Gastroprotective activity of the novel histamine H3-receptor agonist FUB 407
    Morini, G
    Grandi, D
    Sasse, A
    Stark, H
    Schunack, W
    [J]. INFLAMMATION RESEARCH, 2001, 50 : S116 - S117
12345